Dual trigger of oocyte maturation with gonadotropin-releasing hormone agonist and low-dose human chorionic gonadotropin to optimize live birth rates in high responders

Fertility and Sterility

Volumn 97, Issue 6, 2012, Pages 1316-1320

  Griffin, Daniel ^a   Benadiva, Claudio ^a   Kummer, Nicole ^a   Budinetz, Tara ^a   Nulsen, John ^a   Engmann, Lawrence ^a  

^a UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

Author keywords

dual trigger; GnRH agonist; IVF; luteal phase support; OHSS

Indexed keywords

CHORIONIC GONADOTROPIN; ESTRADIOL; GANIRELIX; GONADORELIN AGONIST; HUMAN MENOPAUSAL GONADOTROPIN; LEUPRORELIN; PROGESTERONE; RECOMBINANT FOLLITROPIN;

ADULT; ARTICLE; COHORT ANALYSIS; DRUG DOSE INCREASE; ECTOPIC PREGNANCY; FEMALE; FERTILIZATION; FERTILIZATION IN VITRO; HORMONE BLOOD LEVEL; HUMAN; INTRACYTOPLASMIC SPERM INJECTION; LIVE BIRTH; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MULTIPLE CYCLE TREATMENT; NIDATION; OOCYTE MATURATION; OUTCOME ASSESSMENT; OVARY HYPERSTIMULATION; PREGNANCY RATE; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ABORTION, SPONTANEOUS; ADULT; CHORIONIC GONADOTROPIN; DATABASES, FACTUAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; EMBRYO IMPLANTATION; FEMALE; GONADOTROPIN-RELEASING HORMONE; HUMANS; INFERTILITY, FEMALE; LUTEAL PHASE; OOCYTES; OVARIAN HYPERSTIMULATION SYNDROME; PREGNANCY; PREGNANCY RATE; REPRODUCTIVE CONTROL AGENTS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84861651794     PISSN: 00150282     EISSN: 15565653     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2012.03.015     Document Type: Article

References (23)

1. E. Zivi, A. Simon, and N. Laufer Ovarian hyperstimulation syndrome: definition, incidence, and classification Semin Reprod Med 28 2010 441 447
2. A.J. DiLuigi, L. Engmann, D.W. Schmidt, D.B. Maier, J.C. Nulsen, and C.A. Benadiva Gonadotropin-releasing hormone agonist to induce final oocyte maturation prevents the development of ovarian hyperstimulation syndrome in high-risk patients and leads to improved clinical outcomes compared with coasting Fertil Steril 94 2010 1111 1114
3. L. Engmann, A. DiLuigi, D. Schmidt, J. Nulsen, D. Maier, and C. Benadiva The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomized controlled study Fertil Steril 89 2008 84 91
4. L. Engmann, L. Siano, D. Schmidt, J. Nulsen, D. Maier, and C. Benadiva GnRH agonist to induce oocyte maturation during IVF in patients at high risk of OHSS Reprod Biomed Online 13 2006 639 644
5. P. Humaidan, H.E. Bredkjaer, L. Bungum, M. Bungum, M.L. Grondahl, and L. Westergaard GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized study Hum Reprod 20 2005 1213 1220
6. E.M. Kolibianakis, A. Schultze-Mosgau, A. Schroer, A. van Steirteghem, P. Devroey, and K. Diedrich A lower ongoing pregnancy rate can be expected when GnRH agonist is used for triggering final oocyte maturation instead of HCG in patients undergoing IVF with GnRH antagonists Hum Reprod 20 2005 2887 2892
7. N. Kummer, C. Benadiva, R. Feinn, J. Mann, J. Nulsen, and L. Engmann Factors that predict the probability of a successful clinical outcome after induction of oocyte maturation with a gonadotropin-releasing hormone agonist Fertil Steril 96 2011 63 68
8. B.S. Shapiro, S.T. Daneshmand, F.C. Garner, M. Aguirre, and S. Thomas Gonadotropin-releasing hormone agonist combined with a reduced dose of human chorionic gonadotropin for final oocyte maturation in fresh autologous cycles of in vitro fertilization Fertil Steril 90 2008 231 233
9. E.G. Papanikolaou, C. Pozzobon, E.M. Kolibianakis, M. Camus, H. Tournaye, and H.M. Fatemi Incidence and prediction of ovarian hyperstimulation syndrome in women undergoing gonadotropin-releasing hormone antagonist in vitro fertilization cycles Fertil Steril 85 2006 112 120
10. A. Golan, and A. Weissman Symposium: update on prediction and management of OHSS. A modern classification of OHSS Reprod Biomed Online 19 2009 28 32
11. P. Humaidan, S. Kol, and E.G. Papanikolaou GnRH agonist for triggering of final oocyte maturation: time for a change of practice? Hum Reprod Update 17 2011 510 524
12. D. Bodri, J.J. Guillen, A. Galindo, D. Mataro, A. Pujol, and O. Coll Triggering with human chorionic gonadotropin or a gonadotropin-releasing hormone agonist in gonadotropin-releasing hormone antagonist-treated oocyte donor cycles: findings of a large retrospective cohort study Fertil Steril 91 2009 365 371
13. R. Babayof, E.J. Margalioth, M. Huleihel, A. Amash, E. Zylber-Haran, and M. Gal Serum inhibin A, VEGF and TNFalpha levels after triggering oocyte maturation with GnRH agonist compared with hCG in women with polycystic ovaries undergoing IVF treatment: a prospective randomized trial Hum Reprod 21 2006 1260 1265
14. L. Engmann, and C. Benadiva Ovarian hyperstimulation syndrome prevention strategies: Luteal support strategies to optimize pregnancy success in cycles with gonadotropin-releasing hormone agonist ovulatory trigger Semin Reprod Med 28 2010 506 512
15. M.B. Zelinski-Wooten, S.E. Lanzendorf, D.P. Wolf, Y.A. Chandrasekher, and R.L. Stouffer Titrating luteinizing hormone surge requirements for ovulatory changes in primate follicles. I. Oocyte maturation and corpus luteum function J Clin Endocrinol Metab 73 1991 577 583
16. M.B. Zelinski-Wooten, J.S. Hutchison, Y.A. Chandrasekher, D.P. Wolf, and R.L. Stouffer Administration of human luteinizing hormone (hLH) to macaques after follicular development: further titration of LH surge requirements for ovulatory changes in primate follicles J Clin Endocrinol Metab 75 1992 502 507
17. Y.A. Chandrasekher, R.M. Brenner, T.A. Molskness, Q. Yu, and R.L. Stouffer Titrating luteinizing hormone surge requirements for ovulatory changes in primate follicles. II. Progesterone receptor expression in luteinizing granulosa cells J Clin Endocrinol Metab 73 1991 584 589
18. N.G. Beckers, N.S. Macklon, M.J. Eijkemans, M. Ludwig, R.E. Felberbaum, and K. Diedrich Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment J Clin Endocrinol Metab 88 2003 4186 4192
19. O. Nevo, T. Eldar-Geva, S. Kol, and J. Itskovitz-Eldor Lower levels of inhibin A and pro-alphaC during the luteal phase after triggering oocyte maturation with a gonadotropin-releasing hormone agonist versus human chorionic gonadotropin Fertil Steril 79 2003 1123 1128
20. P. Humaidan, H. Ejdrup Bredkjaer, L.G. Westergaard, and C. Yding Andersen 1,500 IU human chorionic gonadotropin administered at oocyte retrieval rescues the luteal phase when gonadotropin-releasing hormone agonist is used for ovulation induction: a prospective, randomized, controlled study Fertil Steril 93 2010 847 854
21. J.C. Castillo, M. Dolz, E. Bienvenido, L. Abad, E.M. Casan, and F. Bonilla-Musoles Cycles triggered with GnRH agonist: exploring low-dose hCG for luteal support Reprod Biomed Online 20 2010 175 181
22. E.G. Papanikolaou, W. Verpoest, H. Fatemi, B. Tarlatzis, P. Devroey, and H. Tournaye A novel method of luteal supplementation with recombinant luteinizing hormone when a gonadotropin-releasing hormone agonist is used instead of human chorionic gonadotropin for ovulation triggering: a randomized prospective proof of concept study Fertil Steril 95 2011 1174 1177
23. B.S. Shapiro, S.T. Daneshmand, F.C. Garner, M. Aguirre, and C. Hudson Comparison of "triggers" using leuprolide acetate alone or in combination with low-dose human chorionic gonadotropin Fertil Steril 95 2011 2715 2717